CIBC Private Wealth Group
AZN icon

CIBC Private Wealth Group’s AstraZeneca AZN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$533M Buy
8,218,863
+112,867
+1% +$7.33M 1.13% 12
2024
Q4
$540M Sell
8,105,996
-984,362
-11% -$65.5M 0.98% 15
2024
Q3
$708M Sell
9,090,358
-122,429
-1% -$9.54M 1.27% 11
2024
Q2
$711M Sell
9,212,787
-81,996
-0.9% -$6.32M 1.33% 10
2024
Q1
$625M Sell
9,294,783
-1,130,131
-11% -$76M 1.22% 13
2023
Q4
$709M Buy
10,424,914
+889,178
+9% +$60.4M 1.5% 9
2023
Q3
$646M Sell
9,535,736
-438,164
-4% -$29.7M 1.53% 9
2023
Q2
$714M Buy
9,973,900
+63,209
+0.6% +$4.52M 1.56% 7
2023
Q1
$688M Sell
9,910,691
-857,717
-8% -$59.5M 1.52% 13
2022
Q4
$417M Sell
10,768,408
-45,532
-0.4% -$1.76M 1.4% 14
2022
Q3
$593M Buy
10,813,940
+83,177
+0.8% +$4.56M 1.6% 9
2022
Q2
$709M Buy
10,730,763
+1,490,165
+16% +$98.5M 1.84% 7
2022
Q1
$613M Buy
9,240,598
+1,248,900
+16% +$82.9M 1.34% 10
2021
Q4
$466M Buy
7,991,698
+633,767
+9% +$36.9M 0.97% 20
2021
Q3
$442M Buy
7,357,931
+697,507
+10% +$41.9M 1.03% 18
2021
Q2
$399M Buy
6,660,424
+243,614
+4% +$14.6M 0.92% 23
2021
Q1
$319M Buy
6,416,810
+1,693,064
+36% +$84.2M 0.8% 32
2020
Q4
$236M Buy
4,723,746
+942,954
+25% +$47.1M 0.62% 48
2020
Q3
$207M Buy
3,780,792
+3,765,425
+24,503% +$206M 0.63% 49
2020
Q2
$813K Sell
15,367
-608,888
-98% -$32.2M ﹤0.01% 482
2020
Q1
$27.9M Sell
624,255
-5,774
-0.9% -$258K 0.12% 144
2019
Q4
$31.4M Buy
630,029
+9,390
+2% +$468K 0.1% 158
2019
Q3
$27.7M Buy
620,639
+1,333
+0.2% +$59.4K 0.1% 170
2019
Q2
$25.6M Sell
619,306
-32,834
-5% -$1.36M 0.09% 188
2019
Q1
$26.4M Sell
652,140
-579,250
-47% -$23.4M 0.1% 174
2018
Q4
$46.8M Buy
1,231,390
+805,985
+189% +$30.6M 0.21% 126
2018
Q3
$16.8M Buy
425,405
+422,557
+14,837% +$16.7M 0.06% 230
2018
Q2
$100K Buy
2,848
+559
+24% +$19.6K ﹤0.01% 1028
2018
Q1
$80K Sell
2,289
-9,281
-80% -$324K ﹤0.01% 1061
2017
Q4
$402K Buy
+11,570
New +$402K ﹤0.01% 824
2016
Q1
Sell
-13,240
Closed -$449K 580
2015
Q4
$449K Buy
13,240
+284
+2% +$9.63K ﹤0.01% 535
2015
Q3
$412K Buy
+12,956
New +$412K ﹤0.01% 548